Suppr超能文献

低蛋白血症的危重症老年患者对肠内管饲饮食的耐受性

Tolerance to enteral tube feeding diets in hypoalbuminemic critically ill, geriatric patients.

作者信息

Borlase B C, Bell S J, Lewis E J, Swails W, Bistrian B R, Forse R A, Blackburn G L

机构信息

Department of Surgery, Harvard Medical School, Deaconess Hospital, Boston, Massachusetts 02215.

出版信息

Surg Gynecol Obstet. 1992 Mar;174(3):181-8.

PMID:1542832
Abstract

Tolerance of elemental (for example, Peptamen [PEP]) or free amino acid (for example, Vivonex TEN [VIV]) tube feeding diets is controversial, especially in the critically ill patient who is hypoalbuminemic. A prospective, randomized trial was conducted to compare differences between feeding PEP (n = 8) or VIV (n = 8) in critically ill, elderly (average age of 66 years) patients. Diets were administered through nasogastric or postpyloric feeding tubes. Eleven patients had diseases of the gastrointestinal tract; all underwent surgical treatment. Patients were fed each diet at full strength, beginning with 20 to 30 milliliters per hour and advancing by 10 to 20 milliliters every day until goal rate was reached, usually on day 4. Assessment was made for ability to comply with rate of tube feeding ordered, compliance with caloric goal and tolerance (as evidenced by abdominal discomfort and diarrhea). Diarrhea was qualitatively defined as more than three stools per day and then quantitatively as the mean number of stools daily. There were no significant differences between the two groups in terms of compliance with prescribed tube feeding order or caloric goal or the presence of diarrhea and abdominal discomfort. There was a significant difference between the two groups in terms of the actual number of stools per day (PEP equals 1.38 versus VIV equals 2.25, p less than 0.02). Serum albumin concentrations upon initiation of the diets were 2.3 grams per deciliter in both groups. We conclude that tolerance to the two diets were similar because it was possible to feed enterally either PEP or VIV in critically ill, hypoalbuminemic patients (serum albumin concentrations of less than 2.5 grams per deciliter) successfully, irrespective of diet. Although there were more stools in the VIV group, this did not reduce compliance with the goals.

摘要

要素型(如百普素[PEP])或游离氨基酸型(如维沃要素膳[VIV])管饲饮食的耐受性存在争议,尤其是在低白蛋白血症的危重症患者中。进行了一项前瞻性随机试验,比较在危重症老年患者(平均年龄66岁)中给予PEP(n = 8)或VIV(n = 8)的差异。饮食通过鼻胃管或幽门后喂养管给予。11例患者患有胃肠道疾病;均接受了手术治疗。患者以全量开始接受每种饮食,起始速度为每小时20至30毫升,每天增加10至20毫升,直至达到目标速度,通常在第4天达到。评估指标包括遵守规定的管饲速度的能力、遵守热量目标的情况以及耐受性(以腹部不适和腹泻为证据)。腹泻定性定义为每天排便超过3次,然后定量为每日平均排便次数。两组在遵守规定的管饲医嘱或热量目标或腹泻和腹部不适的发生方面没有显著差异。两组在每日实际排便次数方面存在显著差异(PEP等于1.38,而VIV等于2.25,p小于0.02)。开始饮食时两组的血清白蛋白浓度均为每分升2.3克。我们得出结论,两种饮食的耐受性相似,因为在危重症、低白蛋白血症患者(血清白蛋白浓度低于每分升2.5克)中,无论使用哪种饮食,都可以成功地进行肠内喂养。虽然VIV组的排便次数更多,但这并未降低对目标的依从性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验